Screening system taking Chals gene as selective marker site and application of screening system
By mutating the Chals gene and building a targeted integration vector, the unpredictability of random integration and insufficient marker sites in fungal genetic transformation are solved, and an efficient targeted integration and screening system in Anthrax in Higgins is achieved, ensuring the gene Functional stability and feasibility of multiple conversions.
Patent Information
- Application Number
- CN202410908155.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-08
- Publication Date
- 2024-11-08
AI Technical Summary
The unpredictability of randomly integrating DNA in fungal genetic transformation and possible genetic mutation problems, especially when using fluorescent protein tags or other tags, leads to deletion of gene function regulation and phenotype abnormalities, and lack of effective options sexual marker loci affects the feasibility of multiple genetic transformation operations.
Develop a selective marker site based on the Chals gene, which mutates the 886th base in the Chals gene, confers the insensitiveness of Anthrax Higgins to chloropysulfuron, constructs an expression vector for directed integration of exogenous sequences, and Use fluorescent protein labeling to achieve cell nuclear fluorescent labeling, and realize the application of targeted integration and screening systems in fungi.
It realizes stable expression and screening of targeted integrated exogenous sequences without affecting the normal growth and pathogenicity of the strain, and provides an efficient positive transformant screening method without requiring additional resistance markers. Ensures the accuracy of regulation of gene function and the feasibility of multiple genetic transformations.
Smart Images

Figure CN118910108A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of fungal gene engineering, and more specifically, to a screening system using Chals gene as a selective marker site and its application. Background Art
[0002] Colletotrichum fungi of the Ascomycetes are a class of plant pathogenic fungi with important economic significance, which can infect a large number of plants including economic crops. Because they are distributed all over the world, Colletotrichum fungi are recognized by the academic community as one of the top ten important plant pathogenic fungi. Among them, Colletotrichum higginsianum, which causes anthracnose on cruciferous vegetables, has been used as a model fungus to study the interaction between plants and pathogenic fungi at the molecular level. On the one hand, Colletotrichum higginsianum is easy to culture and genetic strains can be efficiently obtained through Agrobacterium-mediated genetic transformation; on the other hand, the whole genome sequence and transcriptome data of Colletotrichum higginsianum have been reported. Combining these two reasons, Colletotrichum higginsianum is an excellent material for studying the pathogenic mechanism of plant pathogenic fungi and has good development and application prospects.
[0003] With the development of biotechnology, the use of molecular biology methods to study pathogens has become one of the most common methods. Molecular research in fungal biology relies heavily on genetic transformation operations, which involves knocking out the coding gene sequence or introducing exogenous DNA sequences to study the function of genes. In most filamentous fungi, transformation is achieved by randomly integrating DNA fragments into any position in the genome through non-homologous end joining (NHEJ) or by integrating DNA into a specific position in the genome through homologous recombination (HR).
[0004] Among them, the main disadvantage of random integration is its unpredictable position effect. Different gene expressions may exist on different integrants. At the same time, random insertion may also cause mutation events in other genes, affecting the original functions of other genes. At present, when it is necessary to introduce fluorescent protein tags or other protein tags, the method usually adopted is to randomly integrate these tags into the genome. In addition, there is no clear standard for the complementation strategy in gene function research at this stage. If the original gene is complemented to the original position on the genome by homologous recombination, it is often necessary to integrate a very long expression frame into the genome, which includes the selection tag and homology arm fragment under the strong promoter. Such a complementation strategy may cause abnormal function of adjacent genes or adjacent non-coding RNA regions, resulting in the lack of regulation of the targeted gene function, thereby causing phenotypic abnormalities in the complemented strain.
[0005] Effective marker and screening systems are of great significance in genetic transformation experiments. A large number of genes have been found to be suitable as selective markers for fungi. In order to obtain transgenic strains more effectively, antibiotic-resistant genes are usually selected as markers for screening. In the context of a large number of filamentous fungal genomes being sequenced, it is revealed that there are a large number of homologous genes, and they have a certain redundancy in gene function. In the study of these gene functions, multiple genetic transformation operations are often required. On the one hand, due to the insertion of too many resistance markers, it is possible to affect not only the normal expression of the strain's own genes, but also its normal growth. On the other hand, the limited marker genes in filamentous fungi also hinder multiple genetic transformation operations.
[0006] In order to better solve the above problems, in recent years, a new strategy of specific integration based on selective marker sites has been developed and applied in some filamentous fungi. The pyrG gene in Aspergillus niger, the sdi1 gene in Ustilago maydis, Zymoseptoria tritic and Pyricularia oryzae and the ILV2 gene in Magnaporthe oryzae. Among them, in the integration of the ILV2 gene site, only a single amino acid replacement is required to confer resistance to chlorimuron-methyl on the recipient strain, and other properties of the recipient strain are not changed, and screening can be effectively and quickly performed in genetic transformation. Therefore, in view of the problems existing in the current filamentous fungal genetic operating system, it is of great significance to develop a new screening system based on selective marker sites in Higgins anthracnose. Summary of the invention
[0007] The purpose of the present invention is to overcome the above-mentioned defects and shortcomings in the prior art and to provide a screening system using the Chals gene as a selectable marker site.
[0008] The second object of the present invention is to provide application of the screening system in screening fungal genetic transformation systems.
[0009] The third object of the present invention is to provide an expression vector for directed integration of foreign sequences in fungi.
[0010] The fourth object of the present invention is to provide an expression vector for fluorescent labeling of fungal cell nuclei.
[0011] The above-mentioned object of the present invention is achieved through the following technical solutions:
[0012] The present invention has found a selective marker site of Higgins anthrax (Colletotrichum higginsianum), which is based on a mutation event occurring on the Chals gene (Gene ID: 2887055), wherein the mutation event is a mutation at the 886th base in the Chals gene, wherein the mutation is a mutation of cytosine to adenine (C886A), and the 200th amino acid is replaced by aspartic acid (Ala200Asp) from the original alanine. The mutation event confers the situation that the Higgins anthrax inoculated on the basal (BM) medium is insensitive to chlorimuron-methyl, and can be applied to optimize the genetic transformation system. Specifically, by mutating the 886th base in the Chals gene of Higgins anthrax, the mutant strain is insensitive to the herbicide chlorimuron-methyl when inoculated on the basal (BM) medium, and effective screening of positive transformants can be achieved without adding a screening gene. Therefore, the present invention develops a screening system based on the selective marker site of the Chals gene in Higgins anthrax bacteria, and on this basis constructs a mutant strain expressing an exogenous fusion protein to verify the feasibility of site-directed integration of an exogenous sequence at the Chals gene site. Experiments have confirmed that the mutant strain does not affect the normal colony growth, appressorium morphology and pathogenicity of Higgins anthrax bacteria, and the directed integrated exogenous DNA sequence can be expressed normally, proving the operability and stability of the directed integration exogenous sequence strategy described in the present invention, which can be applied to the genetic transformation system to solve the technical problem of lack of suitable integration sites for exogenous sequences, and has good application prospects.
[0013] The present invention first provides a screening system using a Chals gene as a selective marker site. The screening system comprises an expression vector, wherein the expression vector contains a Chals gene with a mutated base at position 886; the gene ID of the Chals gene sequence is 2887055, and the mutation is that the base at position 886 of the Chals gene is mutated from cytosine (C) to adenine (A), and the amino acid at position 200 of the Chals gene is replaced from alanine (GCC) to aspartic acid (GAC).
[0014] Furthermore, the nucleotide sequence of the Chals gene with the 886th base mutation is shown in SEQ ID No.1.
[0015] Preferably, the amino acid sequence of the protein expressed by the Chals gene with the 886th base mutation is as shown in SEQ ID No.2.
[0016] The invention provides application of the screening system in constructing a mutant strain with resistance to chlorimuron-methyl.
[0017] Furthermore, the strain is Higgins anthrax.
[0018] The present invention provides an application of the screening system in fungal genetic transformation system screening. Specifically, the fungal genetic transformation system screening is: in the genetic transformation process, chlorimuron-methyl is used to achieve screening of positive transformants without inserting a resistance marker.
[0019] Furthermore, the fungus is Higgins Anthrax.
[0020] The present invention provides an expression vector for direct integration of exogenous sequences in fungi, the expression vector comprising the Chals gene with a mutation at the 886th base, a multiple cloning site and a 3' UTR region of the Chals gene; the multiple cloning site is used for direct insertion of an exogenous target gene sequence. The expression vector can insert an exogenous sequence into the multiple cloning site to express an exogenous protein in fungi.
[0021] Furthermore, the length of the UTR sequence region at the 3' end of the Chals gene is 1000 bp.
[0022] Furthermore, the nucleotide sequence of the 3' UTR region of the Chals gene is shown as SEQ ID No.3, and the nucleotide sequence of the multiple cloning site is shown as SEQ ID No.4.
[0023] The present invention provides an expression vector for fungal cell nucleus fluorescence labeling, which is obtained by inserting an exogenous sequence into the expression vector for directed integration of an exogenous sequence in fungi, wherein the exogenous sequence includes a histone sequence containing a nuclear signal and a fluorescent protein expression sequence; that is, the expression region of the expression vector for the cell nucleus fluorescence labeling includes a recombinant fusion protein expression sequence for expressing a recombinant fusion protein of histones and fluorescent proteins. After entering the target fungal cell, the expression vector for the fungal cell nucleus fluorescence labeling can express a recombinant fusion protein of histones and fluorescent proteins, has a nuclear localization signal, can accurately locate in the cell nucleus, and emits fluorescence after being excited, thereby permanently labeling the cell nucleus of the target fungal cell.
[0024] Furthermore, the histone expression sequence and the fluorescent protein expression sequence are in the reading frame of the same promoter; wherein the histone expression sequence lacks a stop codon and is connected to the upstream of the fluorescent protein expression sequence; the recombinant fusion protein expression sequence has a nuclear localization signal for expressing the recombinant fusion protein. The recombinant fusion protein includes a correctly folded histone nuclear fluorescent protein subunit.
[0025] Furthermore, the histone is Histone 1 (H1) protein, and the fluorescent protein is green fluorescent protein. The Histone 1 (H1) histone is selected to be fused with the fluorescent protein, and the fluorescent signal is stronger. The recombinant fusion protein formed by the fusion of H1 histone and green fluorescent protein, when applied to Higgins anthrax cell nucleus labeling, presents a higher fluorescent signal, clear imaging, accurate positioning, and does not affect the normal physiological activities of Higgins anthrax cells.
[0026] Preferably, there is a 12 bp linker sequence between the histone expression sequence and the fluorescent protein expression sequence.
[0027] Preferably, the nucleotide sequence of the histone is as shown in SEQ ID No.5, the amino acid sequence of the histone is as shown in SEQ ID No.6, and preferably, the nucleotide sequence of the green fluorescent protein is as shown in SEQ ID No.9.
[0028] Furthermore, the exogenous sequence also includes a histone Histone 1 (H1) promoter for initiating the expression sequence of the recombinant fusion protein, and an Aspergillus nidulans TrpC terminator for terminating the expression sequence of the recombinant fusion protein.
[0029] Preferably, the nucleotide sequence of the histone 1 (H1) promoter is shown as SEQ ID No.7, and the nucleotide sequence of the TrpC terminator is shown as SEQ ID No.8.
[0030] Furthermore, the method for preparing the above-mentioned fungal cell nucleus fluorescently labeled expression vector comprises the following steps:
[0031] S1. Clone the histone gene sequence containing the nuclear localization signal sequence, the promoter sequence of histone Histone 1 (H1) protein and the green fluorescent protein gene sequence;
[0032] S2. Connect the histone gene sequence containing the nuclear localization signal sequence, the promoter sequence of the histone gene and the green fluorescent protein gene sequence to the multiple cloning site of the expression vector for directed integration of exogenous sequences in fungi, so that the histone gene sequence is connected to the upstream of the fluorescent protein sequence.
[0033] Preferably, competent cells can be used to amplify the expression vector labeled with cell nucleus fluorescence, and the specific operation is to transform the expression vector into competent cells and propagate and extract the plasmid; the competent cells are preferably Escherichia coli competent cells.
[0034] The present invention also provides a cell nucleus labeling reagent, comprising a recombinant containing the above-mentioned fungal cell nucleus fluorescent labeling expression vector and having the target fungus infection ability.
[0035] Furthermore, the cell nucleus labeling reagent is used to label the nucleus of Higgins anthrax bacteria, and the recombinant is Agrobacterium, preferably Agrobacterium AGL1.
[0036] Furthermore, the method for preparing the cell nucleus labeling reagent comprises using the above-mentioned fungal cell nucleus fluorescent labeling expression vector to transform a vector having the ability to infect the target fungal cell to be labeled to obtain a recombinant.
[0037] Preferably, the vector is Agrobacterium.
[0038] Preferably, the method comprises culturing and screening the transformed vector to obtain positive recombinants.
[0039] In a preferred embodiment, the expression vector of the fungal nucleus fluorescent marker is transformed into Agrobacterium that can be used to infect Higgins anthrax, and the positive Agrobacterium is screened after cultivation to obtain the Agrobacterium containing the expression vector of the fungal nucleus fluorescent marker.
[0040] The present invention also provides use of the cell nucleus labeling reagent in labeling the cell nuclei of fungal cells.
[0041] Preferably, the cell nucleus labeling reagent is used to label the cell nucleus of Higgins anthrax bacteria.
[0042] Furthermore, the method of using the cell nucleus labeling reagent to label the cell nucleus of a fungal cell comprises infecting and transforming the target fungal cell to be labeled with the cell nucleus labeling reagent.
[0043] Preferably, the method comprises infecting Higgins anthrax conidia with Agrobacterium containing an expression vector for fluorescently labeled nuclei, screening positive transformants after culturing, and obtaining target cells with fluorescently labeled nuclei.
[0044] Further preferably, the method comprises: infecting target fungal cells with the cell nucleus labeling reagent, placing the infected target fungal cells in a culture environment for a selection marker gene, and screening out target fungal cell transformants expressing the selection marker gene.
[0045] A preferred embodiment is that the method is to infect Higgins anthrax conidia with Agrobacterium containing an expression vector for a nuclear fluorescent marker, and then culture the conidia on BM medium containing Chlorimuron Ethyl (CE) and further screen positive transformants to obtain Higgins anthrax transformants containing a nuclear fluorescent marker.
[0046] The BM culture medium formula (1 L) is: 1.7 g yeast basic nitrogen source (without amino acids and ammonium sulfate); 2 g asparagine; 1 g ammonium nitrate; 10 g glucose; 20 g agar, and the pH value is adjusted to 6.0 with disodium hydrogen phosphate.
[0047] Compared with the prior art, the present invention has the following beneficial effects:
[0048] The present invention provides a screening system using Chals gene as a selective marker site, the screening system comprising an expression vector, the expression vector containing a Chals gene with a 886th base mutation; the GeneID of the Chals gene sequence is 2887055, the mutation is that the 886th base of the Chals gene is mutated from cytosine to adenine, and the amino acid at the 200th position of the Chals gene is replaced by aspartic acid from alanine. The screening system can be applied to the screening of fungal genetic transformation systems. On the basis of the screening system, the present invention further provides an expression vector for directional integration of exogenous sequences, which can insert exogenous sequences at multiple cloning sites, realize directional integration of exogenous sequences, and successfully express exogenous fusion proteins in fungi. Taking nuclear fluorescent labeling as an example, the provided nuclear fluorescent labeling expression vector can express a recombinant fusion protein of histones and fluorescent proteins after entering the target fungal cell, has a nuclear localization signal, can accurately locate in the nucleus, emit fluorescence after being excited, and can permanently mark its nucleus, so that the nuclear behavior of living cells under various conditions can be systematically and accurately observed without affecting the growth of hyphae and the morphological construction of appressorium. The research on the pathogenic mechanism of Higgins anthrax is of great significance, and therefore has good application prospects and development space. BRIEF DESCRIPTION OF THE DRAWINGS
[0049] Figure 1 This is a schematic diagram of the mutation vector structure provided by the present invention.
[0050] Figure 2 The growth of Higgins anthrax wild-type strain and Chals mutant strain on BM and BM resistance plates.
[0051] Figure 3 The figure shows the growth of Higgins anthrax wild-type strain and Chals mutant strain on PDA plates.
[0052] Figure 4 The colony diameter statistics of Higgins anthrax wild-type strain and Chals mutant strain on the fourth day.
[0053] Figure 5 The conidia and appressorium morphology of the Higgins anthracis wild-type strain and the Chals mutant strain.
[0054] Figure 6 This is the in vitro inoculation situation of Higgins anthrax wild-type strain and Chals mutant strain.
[0055] Figure 7 This is a schematic diagram of the structure of the expression vector for directed integration of exogenous sequences provided by the present invention.
[0056] Figure 8 This is a schematic diagram of the structure of the cell nucleus fluorescent labeling vector provided by the present invention.
[0057] Fig. 9 The figure is the electrophoresis diagram after amplification of the insert fragment of the Higgins anthrax nuclear fluorescent labeling strain; wherein, a is the result of amplifying the upstream fragment with primers als-H1-eGFP-upt-F / R, 1 to 4 are 4 transformants, and M is a marker with a size of 15000 bp; b is the result of amplifying the downstream fragment with primers als-H1-eGFP-dnt-F / R, 1 to 4 are 4 transformants, and M is a marker with a size of 5000 bp; WT is the wild type control, and ddH2O is the sterile water negative control.
[0058] Fig.10 The nucleus of the conidia of the Higgins anthrax strain with fluorescently labeled nuclei is shown under white light and fluorescence vision. DETAILED DESCRIPTION
[0059] The present invention is further described below in conjunction with the accompanying drawings and specific examples, but the examples do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.
[0060] Unless otherwise specified, the reagents and materials used in the following examples are commercially available.
[0061] Example 1 Mutation vector construction
[0062] In the NCBI database ( https: / / www.ncbi.nlm.nih.gov / gene / ) was used to obtain the Chals gene sequence information (Gene ID: 28870552). Using the Chals gene information as a template, als-F1-F, als-F1-R, als-F2-F, and als-F2-R primers were designed (primer sequences are shown in Table 1, capital letters are gene sequences, lowercase letters are homology arm sequences, and red fonts are introduced mutant bases), respectively, to amplify the upstream fragment (1-886 bp) and downstream fragment (886-2426 bp) of the 886th base of the Chals gene, and introduce mutations (CA) in the primer sequences. The plasmid pSFZY-000 (nucleotide sequence is shown in SEQ ID No. 10) was double-digested with restriction endonucleases HindⅢ and PstⅠ (New England Biolabs), digested at 37℃ for 30min, detected by 1% agarose gel electrophoresis, and the fragments were recovered using the EZ-10 column DNA purification kit (Sangong). The genomic DNA of the wild-type strain of Higgins anthrax (IMI 349063) was used as a template to amplify the F1 and F2 fragments, respectively. The amplification reaction system is shown in Table 2, and the PCR amplification program is shown in Table 3. The F1 and F2 fragments were used as templates to amplify the 001-F1 and 000-F2 fragments with homology arms (primer information is shown in Table 1, amplification reaction system is shown in Table 2, and PCR amplification program is shown in Table 3, the same below). The 000-F1 and 000-F2 fragments were connected to the pSFZY-000 vector using the homologous recombination method. The recombination reaction system is shown in Table 4. All solutions were mixed, reacted at 50°C for 15 minutes, and then immediately transferred to an ice water bath for cooling. The recombinant product was transformed into Escherichia coli DH5α. The transformation method was carried out according to the instructions of the DH5α Competent Cell product.
[0063] Table 1. Primer sequence information
[0064]
[0065] Table 2. PCR amplification reaction system
[0066]
[0067] Table 3. PCR amplification program
[0068]
[0069] Table 4. Recombination reaction system
[0070]
[0071] The plasmid pSFZY-000 vector is a highly efficient binary expression vector for fungi and bacteria, containing a kanamycin resistance gene, which is convenient for verifying positive clones. After transformation, a single colony was picked and PCR verified using the verification primer pSFZY-tF / R. The plasmid of the positive clone was extracted, and the plasmid was verified by enzyme digestion and sequencing. The sequencing results were consistent with those shown in SEQ ID No. 1. This indicates that the mutant vector pSFZY-Chals-mutant (such as Figure 1 The obtained mutant vector was further used to construct the Chals mutant strain.
[0072] Example 2 Obtaining Chals mutant strains
[0073] The mutant plasmid pSFZY-Chals-mutant was transformed into Agrobacterium AGL1. The specific steps are as follows: add 1 μg of plasmid DNA to be transformed into Agrobacterium competent AGL1 cells, set the parameters (C = 25 μF, PC = 200 ohm, V = 1.8 kV), and perform electroporation. The electroporated Agrobacterium culture was spread on a resistant plate containing kanamycin (50 μg / mL) and rifampicin (25 μg / mL) for culture. Then, the Agrobacterium was verified by PCR using primers pSFZY-tF / R.
[0074] A single colony of Agrobacterium containing the recombinant plasmid was placed in 5 mL of LB liquid medium containing kanamycin (50 μg / mL) and shaken at 200 r / min and 28°C for 12 h. Then 1 mL of the shaken bacterial solution was taken and 1 mL of AIM medium containing 1 μL of kanamycin (50 μg / mL) and 2 μL of acetosyringone (200 μmol / mL) was added to a sterile 2 mL centrifuge tube and mixed, and then shaken at 200 r / min and 28°C for another 6 h. Higgins anthracnose conidia were collected and the concentration was adjusted to 1×10 6 / mL. Then, draw 100μL of spore liquid and 100μL of shaken Agrobacterium culture liquid into a sterile 1.5mL centrifuge tube and mix well. Spread a sterile nitrocellulose membrane on an unsolidified AIM (containing acetosyringone) plate, then drop the mixture of spore liquid and AIM medium diagonally on the nitrocellulose membrane, blow dry the droplets in a clean bench, and culture in a dark incubator at 28℃ for 2-3 days.
[0075] Cut the circular plaques grown on the nitrocellulose membrane with a sterile blade and place them in 1 mL of PBS buffer containing 1 μL of streptomycin (50 μg / mL), cephalosporin (100 μg / mL), ampicillin (100 μg / mL) and CE (100 μg / mL). Then scrape the plaques from the nitrocellulose membrane with a sterile inoculation loop and discard the nitrocellulose membrane, and shake the bacterial solution on a vortex shaker. Spread the shaken bacterial solution on a BM plate containing streptomycin (50 μg / mL), cephalosporin (100 μg / mL), ampicillin (100 μg / mL) and CE (100 μg / mL), and place it in a 28°C incubator in the dark for 3 to 4 days.
[0076] The single colonies grown on the plate were picked and subcultured on a new BM medium containing antibiotics. The colonies that could grow on the resistant plate were preliminarily identified as candidate transformants. After the candidate transformants were subcultured three times on the resistant plate, the genomic DNA of the candidate transformants was extracted, and the candidate transformants were verified by PCR using primers als-mut-upt-F / R and als-mut-dnt-F / R. The PCR products were sent to the company for testing and verification. The wild-type strain and the Chals mutant strain were cultured on BM plates and BM plates with CE added, respectively. The growth conditions were as follows: Figure 2 As shown in Figure 2, the wild-type strain and the Chals mutant strain can grow in BM medium; however, in BM medium supplemented with CE, the wild-type strain cannot grow, but the Chals mutant strain can grow.
[0077] Example 3 Effects of Chals point mutation strains on colony morphology, hyphal growth rate, appressorium morphology and pathogenicity of Higgins anthrax
[0078] Point mutations on the Chals gene can give the mutant strain the ability to change from sensitive to insensitive to the herbicide chlorimuron-methyl, and can effectively screen positive transformants without adding screening genes. At the same time, in order to explore whether the point mutation strain can grow normally, we selected several phenotypic indicators such as colony morphology, hyphal growth rate, appressorium morphology and pathogenicity to prove that the point mutation does not affect its growth. The phenotype of the Chals mutant strain was observed by the following methods:
[0079] (1) The WT and Chals mutant strains were cultured in PDA medium at 28°C in the dark for 5 days, and their phenotypes were observed. The diameters of the colonies grown on the PDA medium were measured, and the changes in the colony growth rates were compared. Figure 3As shown in the figure, the aerial hyphae of the Chals mutant strain on the PDA medium are more developed than those of the wild-type strain, and the colony color is similar to that of the wild-type, with black in the center of the colony. The colony diameters of the wild-type strain and the Chals mutant strain on the PDA medium on the 4th day were counted, and the results are as follows Figure 4 As shown, there was no significant difference in colony diameter between the two.
[0080] (2) Spores of the wild-type and Chals mutant strains were collected and their appressorium formation was observed on a hydrophobic slide. Figure 5 As shown, both the wild type and Chals mutant strains can produce conidia, and the conidia can germinate normally to produce appressoria, which can also melanize normally.
[0081] (3) The effect of point mutations in the Chals gene on the pathogenicity of Higgins anthracnose was verified by in vitro inoculation experiments. Spore suspensions of wild-type and Chals mutant strains were dripped onto the surface of detached leaves of Chinese cabbage, and the disease was observed on the fifth day. Figure 6 As shown, compared with the wild-type strain, the Chals mutant strain can also cause lesions on the cotyledons of Chinese cabbage, and the lesion conditions are similar to those of the wild-type strain.
[0082] Example 4 Construction of a nuclear fluorescent labeling vector and obtaining Higgins anthrax bacteria with stable nuclear fluorescent labeling
[0083] In the NCBI database ( https: / / www.ncbi.nlm.nih.gov / gene / ) to obtain the UTR sequence at the 3' end downstream of the Chals gene, and design primers als-UTR-F / R to amplify a UTR sequence with a length of 1,000 bp (SEQ ID No.3), and use this sequence as the downstream homology arm sequence of the expression vector. Using the mutation vector pSFZY-Chals-mutant constructed in Example 1 as the template sequence, use primers als-mut-vector-F / R to amplify a Chals gene sequence with a length of 2304 bp with mutations, and use this sequence as the upstream homology arm sequence of the expression vector. Subsequently, the UTR fragment and the Chals gene fragment with mutations were connected to the pSFZY-MCS plasmid by homologous recombination. The nucleotide sequence of the multiple cloning site (MCS) is shown in SEQ ID No.4. The specific steps refer to Example 1. The successfully constructed plasmid pSFZY-Chals-mut-expression has a structure as shown in the schematic diagram. Figure 7 This plasmid can be used to add exogenous sequences later.
[0084] In the NCBI database ( https: / / www.ncbi.nlm.nih.gov / gene / ) was used to obtain the ChH1 gene sequence information (Gene ID: 28871294) and the promoter sequence information of 1500bp upstream thereof. Primers als-H1-eGFP-F1-F / R were designed to amplify the ChH1 gene and its upstream 1500bp sequence fragment, a total of 2628bp. The nucleotide sequence of the ChH1 gene is shown in SEQ ID No.5, and the amino acid sequence is shown in SEQ ID No.6. Using the plasmid containing the green fluorescent protein gene and the plasmid containing the TrpC terminator sequence as templates, primers als-H1-eGFP-F2-F / R and als-TrpC-F / R were designed to amplify the green fluorescent protein gene and the TrpC terminator sequence, respectively. There is also a 12bp linker sequence at the 5' end of the green fluorescent protein gene. The ChH1 gene and its upstream 1500 bp promoter sequence (SEQ ID No. 7), the green fluorescent protein gene sequence (SEQ ID No. 9) and the TrpC terminator sequence (SEQ ID No. 8) were connected into the MCS multiple cloning site of pSFZY-Chals-mut-expression by homologous recombination. The specific experimental steps refer to Example 1. The successfully constructed plasmid pSFZY-Chals-mut-H1-GFP has a structure as shown in the schematic diagram Figure 8 Its nucleotide sequence is shown in SEQ ID No.11.
[0085] The plasmid pSFZY-Chals-mut-H1-GFP was transformed into Agrobacterium AGL1. For specific experimental steps, please refer to Example 2. Then, Agrobacterium was verified by PCR using primers pSFZY-tF / R. Subsequently, a nuclear fluorescent labeling strain was constructed under the Agrobacterium-mediated genetic transformation system. For specific experimental steps, please refer to Example 2. The single colony grown on the plate was picked up and subcultured on a new BM plate containing antibiotics, and the colonies that can grow on the resistant plate were preliminarily identified as candidate transformants. After the candidate transformants were subcultured three times on the resistant plate, the genomic DNA of the candidate transformants was extracted, and the candidate transformants were verified by PCR using primers als-H1-eGFP-upt-F / R and als-H1-eGFP-dnt-F / R. The amplified upstream fragment of 5171bp and the downstream fragment of 2161bp are the same size as the fragments in the recombinant vector, and the electrophoresis results are as shown in Fig. 9 The PCR product was sent to Bioengineering Corporation for sequencing verification, and the sequencing results were consistent with the fragment in the recombinant vector.
[0086] Hoechst 33342 dye was used to stain the conidia of Higgins anthrax, and the fluorescence and staining of the cell nucleus were observed by laser confocal microscopy; Hoechst 33342 is a blue fluorescent dye that can penetrate the cell membrane and is used for cell nucleus staining. The specific steps of Hoechst 33342 staining observation: Hoechst 33342 dye solution was purchased from Yisheng Biotechnology (Shanghai) Co., Ltd. 1 mg / mL Hoechst 33342 was dissolved in PBS buffer to prepare a working solution of 5 μM Hoechst 33342 dye solution. When staining, the Hoechst 33342 dye solution was added to the biological material to be processed to cover the sample. After staining for 10 minutes, the Hoechst 33342 dye solution was removed and washed 3 times with PBS buffer. Finally, it was observed under a TCS Leica SP8STED 3X inverted microscope system (Leica Microsystems) laser confocal microscope. The excitation wavelength for observing green signal was 488nm, and the emission wavelength was 500-540nm; the excitation wavelength for observing blue signal was 350nm, and the emission wavelength was 460nm. The above was controlled by Leica Application Suite X software (version 3.5.5.19976). The experiment was repeated three times. The experimental results are shown in Fig.10 As shown, nuclear signals were observed in both conidia and appressoria.
Claims
1. A screening system using the Chals gene as a selective marker site, characterized in that: The screening system comprises an expression vector, which contains a Chals gene with a mutated base at position 886; the gene number of the Chals gene sequence is 2887055, and the mutation is that the base at position 886 of the Chals gene is mutated from cytosine to adenine, and the amino acid at position 200 of the Chals gene is replaced by alanine to aspartic acid.
2. The screening system according to claim 1, characterized in that: The nucleotide sequence of the Chals gene with the 886th base mutation is shown in SEQ ID No.
1.
3. Use of the screening system according to claim 1 or 2 in screening fungal genetic transformation systems, characterized in that: The fungal genetic transformation system screening is as follows: in the genetic transformation process, under the premise of not inserting a resistance marker, chlorimuron-ethyl is used to achieve the screening of positive transformants.
4. The use according to claim 3, characterized in that: The fungus is Higgins Anthrax.
5. An expression vector for directed integration of exogenous sequences in fungi, characterized in that: The expression vector comprises the Chals gene with a mutation at the 886th base as described in claim 2, a multiple cloning site and the 3' UTR region of the Chals gene; the multiple cloning site is used for directional insertion of an exogenous target gene sequence.
6. The expression vector according to claim 5, characterized in that The nucleotide sequence of the 3' UTR region of the Chals gene is shown in SEQ ID No.
3.
7. The expression vector according to claim 5, characterized in that The nucleotide sequence of the multiple cloning site is shown as SEQ ID No.
4.
8. A fungal cell nucleus fluorescently labeled expression vector, characterized in that: The method is obtained by inserting an exogenous sequence into the expression vector according to any one of claims 5 to 7; the exogenous sequence includes a histone sequence containing a nuclear signal and a fluorescent protein expression sequence.
9. The expression vector according to claim 8, characterized in that The histone expression sequence and the fluorescent protein expression sequence are in the reading frame of the same promoter; wherein the histone expression sequence lacks a stop codon and is connected to the upstream of the fluorescent protein expression sequence.
10. The expression vector according to claim 8, characterized in that The histone is Histone 1 protein, and the fluorescent protein is green fluorescent protein.
